Obesity Today—November 18, 2025
Weekly Obesity update featuring major pipeline moves, regulatory and access…
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal…
AI in Healthcare and Digital Health Today—November 10, 2025
This week’s AI in Healthcare and Digital Health brief distills AI-driven…
AHA 2025 Preview: Key Cardiovascular Highlights to Watch
AHA 2025 at a glance Get ready for AHA 2025 with LucidQuest’s concise preview.…
Endocrinology Today — October 28, 2025
Endocrinology news this week covers major developments, updates, launches and…
Obesity Today — October 28, 2025
Catch the latest obesity news, featuring industry updates, clinical progress,…
Obesity Video Recap — October 28, 2025
Join us for this biweekly roundup of obesity news, where we summarize important…
Public Health Today - October 17, 2025
This week's public health update highlights major developments in disease…
Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)
This top obesity news video summary includes Chugai’s in-licensing of…
Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
Obesity news this week include Chugai in-licensing Roche’s dual incretin CT-388…
EASD 2025 Preview: Key Diabetes Highlihts to Watch
EASD 2025 at a glance In the lead-up to EASD 2025, LucidQuest spotlights…
Obesity Weekly News - August 19th 2025
Obesity Update: Enobosarm’s Oral Release, AI-Powered Drug Discovery, £85M…